Organon Financial Statements From 2010 to 2024

OGN Stock  USD 15.28  0.39  2.62%   
Organon financial statements provide useful quarterly and yearly information to potential Organon Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Organon financial statements helps investors assess Organon's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Organon's valuation are summarized below:
Gross Profit
3.9 B
Profit Margin
0.203
Market Capitalization
3.9 B
Enterprise Value Revenue
1.8601
Revenue
6.4 B
We have found one hundred twenty available trending fundamental ratios for Organon, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to check out Organon's recent fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 25th of November 2024, Enterprise Value is likely to drop to about 8.7 B

Organon Total Revenue

6.27 Billion

Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Tax Provision of 90.2 M, Interest Expense of 553.4 M or Selling General Administrative of 1.3 B, as well as many indicators such as Price To Sales Ratio of 0.77, Dividend Yield of 0.0839 or Days Sales Outstanding of 60.09. Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
  
Check out the analysis of Organon Correlation against competitors.

Organon Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.9 B12.1 B10.7 B
Slightly volatile
Short and Long Term Debt Total4.9 B8.8 B2.1 B
Slightly volatile
Other Current Liabilities1.3 B1.4 B748 M
Slightly volatile
Total Current Liabilities2.2 B2.9 B1.8 B
Slightly volatile
Other Liabilities239.4 M252 M1.9 B
Slightly volatile
Accounts Payable849.6 M1.3 B519.7 M
Slightly volatile
Cash586.5 M693 M382.5 M
Slightly volatile
Other Assets435.7 M485.1 M623.7 M
Slightly volatile
Cash And Short Term Investments586.5 M693 M382.5 M
Slightly volatile
Net Receivables1.6 B1.7 B1.5 B
Pretty Stable
Good Will3.7 B4.1 B4.5 B
Slightly volatile
Common Stock Shares Outstanding279.5 M256.3 M255.3 M
Slightly volatile
Liabilities And Stockholders Equity11.9 B12.1 B10.7 B
Slightly volatile
Inventory1.1 B1.3 BB
Slightly volatile
Other Current Assets764 M756 M897.5 M
Very volatile
Total Liabilities10.1 B12.1 B6.6 B
Slightly volatile
Total Current Assets4.3 B4.5 B3.8 B
Slightly volatile
Cash And Equivalents444 M811.9 M348.4 M
Slightly volatile
Intangible Assets495.6 M533 M713.9 M
Slightly volatile
Common Stock2.6 M2.7 M4.9 B
Slightly volatile
Property Plant EquipmentB1.4 B824.6 M
Slightly volatile
Property Plant And Equipment Net1.1 B1.2 B801.5 M
Slightly volatile
Non Current Assets Total7.7 B7.5 B6.8 B
Slightly volatile
Non Currrent Assets Other938.1 M1.2 B791.4 M
Slightly volatile
Non Current Liabilities Total8.9 B9.2 B4.6 B
Slightly volatile
Property Plant And Equipment Gross1.7 B2.2 BB
Slightly volatile
Short and Long Term Debt8.6 MM114.2 M
Pretty Stable
Non Current Liabilities Other391.4 M412 M2.1 B
Very volatile
Net Working Capital1.4 B1.6 B2.3 B
Slightly volatile
Common Stock Total Equity2.4 M2.7 M2.9 M
Slightly volatile
Deferred Long Term Liabilities3.2 M3.6 M3.9 M
Slightly volatile

Organon Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision90.2 M95 M825.7 M
Slightly volatile
Interest Expense553.4 M527 M132.4 M
Slightly volatile
Selling General Administrative1.3 B1.7 B1.9 B
Slightly volatile
Total Revenue6.3 B6.3 BB
Slightly volatile
Gross Profit3.7 B3.7 B5.2 B
Slightly volatile
Operating Income1.9 B1.3 B2.7 B
Slightly volatile
EBITB1.2 B2.8 B
Slightly volatile
Cost Of Revenue2.5 B2.5 B3.8 B
Slightly volatile
Income Before Tax639.4 M673 M2.5 B
Slightly volatile
Net Income Applicable To Common Shares1.5 B825.3 M1.8 B
Pretty Stable
Net Income1.4 BB1.8 B
Pretty Stable
Depreciation And Amortization372.1 M236 M1.1 B
Slightly volatile
Other Operating ExpensesB4.9 B6.1 B
Slightly volatile
Net Income From Continuing Ops555.8 M585 M1.9 B
Slightly volatile
Research Development427.4 M528 M378.6 M
Slightly volatile
EBITDA2.2 B1.4 B3.7 B
Slightly volatile
Total Operating Expenses2.3 B2.4 B2.3 B
Slightly volatile
Reconciled Depreciation375.9 M228 M1.1 B
Slightly volatile
Selling And Marketing Expenses185.6 M209 M246.9 M
Slightly volatile
Non Recurring2.4 M2.7 M2.9 M
Slightly volatile

Organon Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation67.3 M101 M59.2 M
Slightly volatile
Free Cash Flow511.1 M538 M2.6 B
Slightly volatile
Begin Period Cash Flow418.6 M706 M652.9 M
Slightly volatile
Depreciation224.2 M236 M1.3 B
Slightly volatile
Capital Expenditures272.3 M261 M173.8 M
Slightly volatile
Total Cash From Operating Activities759 M799 M2.7 B
Slightly volatile
Net Income1.5 BB1.8 B
Pretty Stable
End Period Cash Flow556.3 M693 M632.9 M
Slightly volatile
Change To Netincome230.8 M162.9 M669.4 M
Slightly volatile
Dividends Paid213.4 M294 M169.2 M
Slightly volatile
Cash And Cash Equivalents Changes561.6 M631.8 M688 M
Slightly volatile
Cash Flows Other Operating1.4 B1.6 B1.7 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.770.58770.8752
Slightly volatile
Dividend Yield0.08390.07990.0287
Slightly volatile
Days Sales Outstanding60.0910265.7693
Slightly volatile
Free Cash Flow Yield0.290.14620.326
Slightly volatile
Operating Cash Flow Per Share2.973.130410.7567
Slightly volatile
Stock Based Compensation To Revenue0.01690.01610.0075
Slightly volatile
Capex To Depreciation0.891.10590.5979
Slightly volatile
EV To Sales1.31.87571.1939
Slightly volatile
Free Cash Flow Per Share2.02.107810.0783
Slightly volatile
Inventory Turnover3.181.91253.8843
Slightly volatile
Net Income Per Share7.824.0087.1615
Pretty Stable
Days Of Inventory On Hand112191105
Slightly volatile
Payables Turnover1.821.91411.6913
Slightly volatile
Sales General And Administrative To Revenue0.160.26890.1911
Slightly volatile
Research And Ddevelopement To Revenue0.08850.08430.0462
Slightly volatile
Capex To Revenue0.02890.04170.0226
Slightly volatile
Cash Per Share1.682.71511.4659
Slightly volatile
POCF Ratio3.164.60643.2034
Slightly volatile
Interest Coverage2.42.5218460
Slightly volatile
Payout Ratio0.190.28740.1388
Slightly volatile
Capex To Operating Cash Flow0.340.32670.1168
Slightly volatile
PFCF Ratio4.546.84124.1251
Slightly volatile
Days Payables Outstanding20019170.3174
Slightly volatile
Income Quality1.420.7811.5803
Slightly volatile
EV To Operating Cash Flow15.4414.70285.4302
Slightly volatile
PE Ratio3.673.59784.569
Very volatile
Return On Tangible Assets0.140.14780.3678
Slightly volatile
EV To Free Cash Flow22.9321.83567.7717
Slightly volatile
Earnings Yield0.260.27790.2299
Pretty Stable
Intangibles To Total Assets0.530.42590.5034
Slightly volatile
Current Ratio2.341.54492.2894
Slightly volatile
Receivables Turnover5.673.59125.7106
Slightly volatile
Graham Number4.724.973152.7222
Slightly volatile
Capex Per Share0.781.02260.6657
Slightly volatile
Revenue Per Share34.0124.537836.0558
Slightly volatile
Interest Debt Per Share38.236.385510.2831
Slightly volatile
Debt To Assets0.760.72650.2197
Slightly volatile
Enterprise Value Over EBITDA4.358.18073.48
Slightly volatile
Short Term Coverage Ratios11488.777881.7716
Slightly volatile
Price Earnings Ratio3.673.59784.569
Very volatile
Operating Cycle172292170
Slightly volatile
Days Of Payables Outstanding20019170.3174
Slightly volatile
Dividend Payout Ratio0.190.28740.1388
Slightly volatile
Price To Operating Cash Flows Ratio3.164.60643.2034
Slightly volatile
Price To Free Cash Flows Ratio4.546.84124.1251
Slightly volatile
Pretax Profit Margin0.10.10750.2719
Slightly volatile
Ebt Per Ebit0.960.50640.9105
Slightly volatile
Operating Profit Margin0.340.21220.311
Pretty Stable
Return On Capital Employed0.290.14540.2839
Slightly volatile
Ebit Per Revenue0.340.21220.311
Pretty Stable
Quick Ratio1.721.09421.678
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.371.439626.6923
Slightly volatile
Net Income Per E B T1.61.52010.7957
Slightly volatile
Cash Ratio0.220.23750.2065
Slightly volatile
Cash Conversion Cycle113102110
Pretty Stable
Operating Cash Flow Sales Ratio0.120.12760.2923
Slightly volatile
Days Of Inventory Outstanding112191105
Slightly volatile
Days Of Sales Outstanding60.0910265.7693
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.90.67330.8992
Slightly volatile
Cash Flow Coverage Ratios0.08660.091221.3601
Slightly volatile
Fixed Asset Turnover9.635.294212.1532
Slightly volatile
Capital Expenditure Coverage Ratio2.913.061327.0341
Slightly volatile
Price Cash Flow Ratio3.164.60643.2034
Slightly volatile
Enterprise Value Multiple4.358.18073.48
Slightly volatile
Debt Ratio0.760.72650.2197
Slightly volatile
Cash Flow To Debt Ratio0.08660.091221.3601
Slightly volatile
Price Sales Ratio0.770.58770.8752
Slightly volatile
Return On Assets0.08060.08480.1823
Slightly volatile
Asset Turnover0.760.51940.8221
Slightly volatile
Net Profit Margin0.250.16330.2033
Slightly volatile
Gross Profit Margin0.480.59840.5765
Pretty Stable

Organon Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.1 B8.9 B8.4 B
Very volatile
Enterprise Value8.7 B14.5 B10.3 B
Slightly volatile

Organon Fundamental Market Drivers

Forward Price Earnings5.0302
Cash And Short Term Investments693 M

Organon Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Organon Financial Statements

Organon investors utilize fundamental indicators, such as revenue or net income, to predict how Organon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue206 M216.3 M
Total Revenue6.3 B6.3 B
Cost Of Revenue2.5 B2.5 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.27  0.16 
Research And Ddevelopement To Revenue 0.08  0.09 
Capex To Revenue 0.04  0.03 
Revenue Per Share 24.54  34.01 
Ebit Per Revenue 0.21  0.34 

Pair Trading with Organon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Moving together with Organon Stock

  0.77ME 23Andme HoldingPairCorr
  0.92VALN Valneva SE ADRPairCorr
  0.7VCNX VaccinexPairCorr

Moving against Organon Stock

  0.89BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.88GILD Gilead SciencesPairCorr
  0.85EWTX Edgewise TherapeuticsPairCorr
  0.67VRDN Viridian TherapeuticsPairCorr
  0.63KZR Kezar Life SciencesPairCorr
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out the analysis of Organon Correlation against competitors.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.081
Dividend Share
1.12
Earnings Share
5.05
Revenue Per Share
24.984
Quarterly Revenue Growth
0.041
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.